Different strenghts [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2014-12-22 03:58 (4199 d 13:41 ago) – Posting: # 14133
Views: 5,858

Hi cher0424

❝ ❝ 20 mg new MR vs. 2 × 10 mg IR, hybrid pathway (two clinical studies; individualized doses up to 60 mg). ⇒ Approval of 20 mg.


❝ Can you specify what are these two clinical studies? One BE, and one dose up study?


No. The hybrid pathway in the EU means PK + some clinical stuff in patients (therapeutic equivalence or non-inferiority). In my case I had one comparative BA-study (that’s not BE!) and two TE studies. And yes: In both TE studies dose tritration.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
147 visitors (0 registered, 147 guests [including 33 identified bots]).
Forum time: 18:40 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5